The effects of recombinant interleukin 2 (IL-2) on the in vitro differentiation of human tonsillar B cells which were not preincubated with Staphylococcus aureus Cowan I or with anti-human IgM were investigated. IL-2 was shown to induce the generation of Ig-containing cells in a dose-dependent fashion from 2.5 to 2,500 U IL-2/ml. Conversely, the quantities of Ig secreted in the culture supernatant were found in the majority of experiments to peak at 25 U/ml. The possible presence, in cultures stimulated with IL-2, of cells that were capable of synthesizing Ig but that did not secrete the Ig they have produced was investigated. Among a number of factors tested, we found that gamma-interferon, which did not trigger in vitro B cell differentiation when used alone, can induce an increased secretion of Ig without noticeable change in the number of Ig-containing cells in cultures stimulated with IL-2. The possibility that gamma-interferon and IL-2 act on subsequent steps of in vitro B cell differentiation is discussed.
. L® thi Bich-Thuy, A S Fauci
Title and authors | Publication | Year |
---|---|---|
IL-17 Augments B Cell Activation in Ocular Surface Autoimmunity
B Subbarayal, SK Chauhan, AD Zazzo, R Dana |
Journal of immunology (Baltimore, Md. : 1950) | 2016 |
Advances in Immunology
E Pinaud, M Marquet, R Fiancette, S Péron, C Vincent-Fabert, Y Denizot, M Cogné |
Advances in Immunology Volume 110 | 2011 |
Novartis Foundation Symposia
EJ Campbell |
Ciba Foundation Symposium 44 - Research and Medical Practice: Their Interaction | 2008 |
Cell senescence in rat kidneys in vivo increases with growth and age despite lack of telomere shortening
A Melk, W Kittikowit, I Sandhu, KM Halloran, P Grimm, BM Schmidt, PF Halloran |
Kidney International | 2003 |
Current Protocols in Immunology
EH Leiter |
Current Protocols in Immunology | 2001 |
Telomere Shortening in Kidneys with Age
A Melk, VI Ramassar, LM Helms, R Moore, DA Rayner, K Solez, PF Halloran |
Journal of the American Society of Nephrology : JASN | 2000 |
The role of cytokines in human B-cell differentiation into immunoglobulin-secreting cells
O Garraud, TB Nutman |
Bulletin de l'Institut Pasteur | 1996 |
Growth hormone inhibits normal B-cell differentiation and neutrophils' chemotaxis in vitro
MC Fornari, MP Scolnik, MF Palacios, AD Intebi, RA Diez |
International Journal of Immunopharmacology | 1994 |
Anaesthesia and the immune response
L Gunzenhaeuser, GC Mougdil, A Mathieu |
Baillière's Clinical Anaesthesiology | 1991 |
Restoration of high immunoglobulin gene expression in chronic lymphoid leukemia: A possible application for gene therapy
PJ Tremisi, LT Bich-Thuy |
Cellular Immunology | 1991 |
Application of Products Produced Through Biotechnology in Infectious Diseases
SE Gorman, K Plaisance |
Journal of Pharmacy Practice | 1991 |
High-affinity receptors for interleukin-2 are not required for the induction of human unstimulated B lymphocyte differentiation by this lymphokine
L Bich-Thuy |
Cellular Immunology | 1990 |
Cytokines and B Lymphocytes
J Gordon |
Cytokines and B Lymphocytes | 1990 |
The immunomodulatory effects of interferon-gamma on mature B-lymphocyte responses
A Jurado, J Carballido, H Griffel, HK Hochkeppel, GD Wetzel |
Experientia | 1989 |
Interleukin (IL) 4 counteracts the helper effect of IL 2 on antigen-activated human B cells
L Llorente, MC Crevon, S Karray, T Defrance, J Banchereau, P Galanaud |
European Journal of Immunology | 1989 |
Interleukin 2 and interferon-γ affect human B cells at different stages of activation
J Punnonen, MK Viljanen |
APMIS | 1989 |
Peripheral blood lymphocytes of patients with common variable immunodeficiency (CVI) produce reduced levels of interleukin-4, interleukin-2 and interferon-gamma, but proliferate normally upon activation by mitogens
G Pastorelli, MG Roncarolo, JL Touraine, G Peronne, PA Tovo, JE de Vries |
Clinical & Experimental Immunology | 1989 |
Recombinant interferon-γ in the treatment of systemic sclerosis
A Kahan, B Amor, CJ Menkes, G Strauch |
The American Journal of Medicine | 1989 |
Interferon-α and interferon-γ as regulators of human adult and newborn B-cell function
J Punnonen, MK Viljanen |
International Journal of Immunopharmacology | 1989 |
Immunotherapy of Disease
TJ Hamblin |
1989 | |
Novel interleukin 2 (IL-2) receptor appears to mediate IL-2-induced activation of natural killer cells
JH Kehrl, M Dukovich, G Whalen, P Katz, AS Fauci, WC Greene |
Journal of Clinical Investigation | 1988 |
Generation of High-Rate Ovalbumin-Specific Antibody-Secreting Cells in Cultures of Human Peripheral Blood B Cells Obtained from Non-Immunized Blood Donors
LA HART, J Zijlstra, JJ Heijnen, RE Ballieux |
Scandinavian Journal of Immunology | 1988 |
Interferon-alpha can synergize with interleukin 2 for human in vitro antibody response
JF Delfraissy, C Wallon, P Galanaud |
European Journal of Immunology | 1988 |
Festschrift Interleukins: From purified proteins to chains, circles, cascades and other complexities
JW Schrader |
Immunology and Cell Biology | 1988 |
Restricted production of interleukin 4 by activated human T cells
DB Lewis, KS Prickett, A Larsen, K Grabstein, M Weaver, CB Wilson |
Proceedings of the National Academy of Sciences | 1988 |
Transfection of an immunoglobulin kappa gene into mature human B lymphocytes
LT Bich-Thuy, C Queen |
Molecular and cellular biology | 1988 |
In vitro induction of T cell-dependent B cell differentiation in patients with common varied immunodeficiency
W Stohl, C Cunningham-Rundles, L Mayer |
Clinical Immunology and Immunopathology | 1988 |
The CD2/LFA-3 interaction: An alternative pathway of T-cell activation
MT Rugeles, G Virella |
Clinical Immunology Newsletter | 1988 |
Examination of the inhibitory and stimulatory effects of IFN-α, -β, and -γ on human B-cell proliferation induced by various B-cell mitogens
DT Francois, IM Katona, CH June, LM Wahl, JJ Mond |
Clinical Immunology and Immunopathology | 1988 |
Future developments in interferon therapy
M Boiron |
International Journal of Cancer | 1987 |
Autologous Red Blood Cells Potentiate Antibody Synthesis by Unfractionated Human Mononuclear Cell Cultures
MT Rugeles, ML Via, JM Goust, JM Kilpatrick, B Hyman, G Virella |
Scandinavian Journal of Immunology | 1987 |
Enhancement of thyrocyte HLA class II expression by thyroid stimulating hormone
I Todd, R Pujol-Borrell, LJ Hammond, JM McNally, M Feldmann, GF Bottazzo |
Clinical & Experimental Immunology | 1987 |
Functional and biochemical characterization of B-cell differentiation factor (BCDF) produced by an HTLV-I-transformed human T-cell clone and demonstration of specific binding of the factor to a BCDF responsive cell line
H Goldstein, JL Ambrus, JH Grove, JB Margolick, AS Fauci |
Cellular Immunology | 1987 |
Preexposure of resting B cells to interferon-γ enhances their proliferative response to subsequent activation signals
AW Boyd, TF Tedder, JD Griffin, AS Freedman, DC Fisher, J Daley, LM Nadler |
Cellular Immunology | 1987 |
Interferon-β2 living up to its name
M Revel, A Zilberstein |
Nature | 1987 |
Interleukin-2 effects on human B cells activatedin vivo
T Miyawaki, T Suzuki, JL Butler, MD Cooper |
Journal of Clinical Immunology | 1987 |
Progress in the Understanding of Inducible Models of Chronic Arthritis
FC Breedveld, DE Trentham |
Rheumatic diseases clinics of North America | 1987 |